The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 182, 2385 -2394
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0802811

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mong, P. Y.
Right arrow Articles by Wang, Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mong, P. Y.
Right arrow Articles by Wang, Q.

Activation of Rho Kinase Isoforms in Lung Endothelial Cells during Inflammation1

Phyllus Y. Mong and Qin Wang2

The Tumor Immunology Laboratory, Division of Surgical Oncology, Department of Surgery, Columbia University, New York, NY 10032

Rho kinase (ROCK) is a downstream effector of Rho family GTPases, and two highly homologous isoforms, ROCK1 and ROCK2, are similarly inhibited by the widely used pharmacologic inhibitors. In endothelial cells (ECs), activation of ROCK regulates myosin L chain (MLC) phosphorylation, stress fiber formation and permeability increases during inflammation. This study examined isoform-specific ROCK activation in lung ECs in vitro using human pulmonary microvascular ECs and ex vivo using freshly isolated lung ECs from mice. In unstimulated human as well as mouse lung ECs, ROCK2 activity was greater than ROCK1 activity. TNF-{alpha} stimulation induced activation of both ROCK1 and ROCK2 in cultured human ECs. Studies using lung ECs freshly isolated from mice showed that intratracheal instillation of LPS induced ROCK activation in lung ECs that was inhibited by treating animals with fasudil, a pharmacologic ROCK inhibitor, and that both ROCK1 and ROCK2 were activated. Small interference RNA targeting ROCK1 or ROCK2 was used to examine their functions in regulating MLC phosphorylation and permeability increases induced by TNF-{alpha} in human ECs. TNF-{alpha}-induced MLC phosphorylation required ROCK activation. Inhibition of ROCK1 alone was not sufficient to prevent TNF-{alpha}-induced MLC phosphorylation, whereas inhibition of ROCK2 prevented TNF-{alpha}-induced late MLC phosphorylation at 24 h. Although ROCK1 was dispensable for TNF-{alpha}-induced MLC phosphorylation, ROCK1 was required for TNF-{alpha}-induced early permeability increases. Therefore, ROCK1 and ROCK2 are both activated by TNF-{alpha} and can be functionally separated in the signaling pathways leading to TNF-{alpha}-induced MLC phosphorylation and permeability increases.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Grant HL070009 from the National Institutes of Health (to Q.W.).

2 Address correspondence and reprint requests to Dr. Qin Wang, Department of Surgery, College of Physicians and Surgeons Building, Room 17-508, Columbia University, 630 West 168th Street, New York, NY 10032. E-mail address: qw2109{at}columbia.edu

3 Abbreviations used in this paper: ROCK, Rho kinase; MLC, myosin L chain; siRNA, small interfering RNA; MYPT, myosin phosphatase target; EC, endothelial cell; PKC, protein kinase C; Ac-LDL, acetylated low-density lipoprotein.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.